Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens-Reference-Cited by-同舟云学术

Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

Published:2016-04 Issue:4 Volume:69 Page:592-598
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sauter Guido,Steurer Stefan,Clauditz Till Sebastian,Krech Till,Wittmer Corinna,Lutz Florian,Lennartz Maximilian,Janssen Tim,Hakimi Nayira,Simon Ronald,von Petersdorff-Campen Mareike,Jacobsen Frank,von Loga Katharina,Wilczak Waldemar,Minner Sarah,Tsourlakis Maria Christina,Chirico Viktoria,Haese Alexander,Heinzer Hans,Beyer Burkhard,Graefen Markus,Michl Uwe,Salomon Georg,Steuber Thomas,Budäus Lars Henrik,Hekeler Elena,Malsy-Mink Julia,Kutzera Sven,Fraune Christoph,Göbel Cosima,Huland Hartwig,Schlomm Thorsten

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Classification of prostatic carcinomas;Gleason;Cancer Chemother Rep,1966

2. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma;Epstein;Am J Surg Pathol,2005

3. Standardization of Gleason grading among 337 European pathologists;Egevad;Histopathology,2013

4. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter;Ahyai;Eur Urol,2008

5. Contemporary grading for prostate cancer: implications for patient care;Brimo;Eur Urol,2013

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance;Clinical Genitourinary Cancer;2024-12

2. External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens;BJU International;2024-07-11

3. Robust, credible, and interpretable AI-based histopathological prostate cancer grading;2024-07-10

4. Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage;Histopathology;2024-06-03

5. Cribriform versus Intraductal: How to Determine the Difference;Cancers;2024-05-24